264 filings
Page 3 of 14
UPLOAD
7feugm4pgog6 av
16 Nov 22
Letter from SEC
12:00am
8-K
jy1aurrcfy26xd
10 Nov 22
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
7:01am
8-K
enlltroc8
20 Oct 22
October 2022 Larimar Therapeutics Corporate Presentation
8:11am
8-K
bwhmw8
14 Sep 22
Entry into a Material Definitive Agreement
9:01am
424B5
btyfwyqiz3bsz
14 Sep 22
Prospectus supplement for primary offering
7:28am
8-K
lqukr6c35oe2gzjs0e
14 Sep 22
Other Events
7:05am
8-K
n5kvof
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
5w03g
12 May 22
Departure of Directors or Certain Officers
4:10pm
8-K
ovyqcu
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
139nvyp41gcu98ikmli6
11 Apr 22
Departure of Directors or Certain Officers
4:06pm
8-K
am9iwfd2x
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am
8-K
7gtz9f0yvzpr
28 Feb 22
Results of Operations and Financial Condition
8:16am
8-K
89fvw0 yb
14 Feb 22
Larimar Therapeutics Provides Update on CTI-1601 Clinical Program
12:00am